Medline references for Advanced Glycosylation Endproducts (AGE)
AGE specific references
-
Arterioscler Thromb 1994 Oct;14(10):1521-8:
Schmidt AM; Hori O; Brett J; Yan SD; Wautier JL; Stern D
Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.
-
Diabetes 1992 Oct;41 Suppl 2:52-6:
Vlassara H
Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues.
-
Annu Rev Med 1991;42:159-66:
Brownlee M
Glycosylation products as toxic mediators of diabetic complications.
-
Diabetes Res 1991 Jan;16(1):1-9:
Sensi M; Pricci F; Andreani D; Di Mario U
Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
-
Blood Purif 1990;8(4):223-32:
Vlassara H
Advanced nonenzymatic tissue glycosylation: cell-mediated interactions implicated in the complications associated with diabetes and aging.
-
Prog Clin Biol Res 1989;304:205-18:
Vlassara H; Brownlee M; Cerami A
Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging.
-
Diabetes Care 1988 Nov-Dec;11 Suppl 1:73-9:
Cerami A; Vlassara H; Brownlee M
Role of advanced glycosylation products in complications of diabetes.
References including AGE